Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Non-cash Items (2021 - 2024)

Historic Non-cash Items for Kezar Life Sciences (KZR) over the last 4 years, with Q3 2024 value amounting to $367000.0.

  • Kezar Life Sciences' Non-cash Items rose 66458.33% to $367000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $367000.0, marking a year-over-year increase of 66458.33%. This contributed to the annual value of $118000.0 for FY2023, which is 9923.41% down from last year.
  • Latest data reveals that Kezar Life Sciences reported Non-cash Items of $367000.0 as of Q3 2024, which was up 66458.33% from $63000.0 recorded in Q1 2024.
  • In the past 5 years, Kezar Life Sciences' Non-cash Items ranged from a high of $80.2 million in Q1 2022 and a low of $48000.0 during Q3 2023
  • Moreover, its 4-year median value for Non-cash Items was $9.0 million (2021), whereas its average is $19.2 million.
  • Per our database at Business Quant, Kezar Life Sciences' Non-cash Items tumbled by 9981.04% in 2023 and then soared by 66458.33% in 2024.
  • Kezar Life Sciences' Non-cash Items (Quarter) stood at $77.4 million in 2021, then tumbled by 80.08% to $15.4 million in 2022, then crashed by 99.23% to $118000.0 in 2023, then skyrocketed by 211.02% to $367000.0 in 2024.
  • Its Non-cash Items was $367000.0 in Q3 2024, compared to $63000.0 in Q1 2024 and $118000.0 in Q4 2023.